Cargando…
Model-Based Anticancer Effect of Botulinum Neurotoxin Type A1 on Syngeneic Melanoma Mice
In recent, Botulinum Neurotoxin A1 (BoNT/A1) has been suggested as a potential anticancer agent due to neuronal innervation in tumor cells. Although potential BoNT/A1’s mechanism of action for the tumor suppression has been gradually revealed so far, there were no reports to figure out the exposure-...
Autores principales: | Kang, Won-Ho, Ryu, Hyo-Jeong, Kwak, Seongsung, Yun, Hwi-Yeol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763961/ https://www.ncbi.nlm.nih.gov/pubmed/35058777 http://dx.doi.org/10.3389/fphar.2021.793349 |
Ejemplares similares
-
Tyrosine Phosphorylation of Botulinum Neurotoxin Protease Domains
por: Toth, Stephen, et al.
Publicado: (2012) -
A Cell Line for Detection of Botulinum Neurotoxin Type B
por: Rust, Aleksander, et al.
Publicado: (2017) -
Commentary: A Cell Line for Detection of Botulinum Neurotoxin Type B
por: Pickett, Andy
Publicado: (2018) -
Comparative Pharmacodynamics Study of 3 Different Botulinum Toxin Type A Preparations in Mice
por: Kwak, Seongsung, et al.
Publicado: (2020) -
Evaluation of the potential herb-drug interaction between Bojungikki-tang and PD-L1 immunotherapy in a syngeneic mouse model
por: Yang, Sung-Yoon, et al.
Publicado: (2023)